LORTAB Trademark

Trademark Overview

On Tuesday, July 2, 2013, a trademark application was filed for LORTAB with the United States Patent and Trademark Office. The USPTO has given the LORTAB trademark a serial number of 86000274. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, November 10, 2020. This trademark is owned by UCB Inc.. The LORTAB trademark is filed in the Pharmaceutical Products category with the following description:

Analgesics; oral analgesics; oral analgesics in solution or liquid form; analgesic preparations; pharmaceutical preparations, namely, an analgesic for human consumption taken orally
lortab

General Information

Serial Number86000274
Word MarkLORTAB
Filing DateTuesday, July 2, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, November 10, 2020
Registration Number4606812
Registration DateTuesday, September 16, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2013

Trademark Statements

Goods and ServicesAnalgesics; oral analgesics; oral analgesics in solution or liquid form; analgesic preparations; pharmaceutical preparations, namely, an analgesic for human consumption taken orally

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 12, 2013
Primary Code005
First Use Anywhere DateFriday, November 1, 2013
First Use In Commerce DateFriday, November 1, 2013

Trademark Owner History

Party NameUCB Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressATLANTA, GA 30080
Party NameUCB Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressATLANTA, GA 30080
Party NameUCB Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressATLANTA, GA 30080

Trademark Events

Event DateEvent Description
Saturday, September 16, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, November 10, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, November 10, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, November 9, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 15, 2020TEAS SECTION 8 & 15 RECEIVED
Monday, September 16, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 4, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 4, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 16, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, August 12, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Sunday, August 10, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 5, 2014STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 16, 2014USE AMENDMENT FILED
Tuesday, August 5, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 16, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, January 21, 2014NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 26, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 6, 2013NOTICE OF PUBLICATION
Wednesday, October 23, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 22, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 22, 2013EXAMINER'S AMENDMENT ENTERED
Tuesday, October 22, 2013ASSIGNED TO LIE
Tuesday, October 22, 2013EXAMINERS AMENDMENT MAILED
Monday, October 21, 2013EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 16, 2013NON-FINAL ACTION MAILED
Tuesday, October 15, 2013NON-FINAL ACTION WRITTEN
Tuesday, October 15, 2013ASSIGNED TO EXAMINER
Friday, July 12, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 5, 2013NEW APPLICATION ENTERED

Related Keywords

lortab analgesics analgesic preparations oral consumption taken orally human pharmaceutical form